InterCure Ltd. has announced an Extraordinary General Meeting of Shareholders on August 12, 2026, to vote on a proposed 5-to-1 reverse share split. The company aims to maintain its Nasdaq Global Market listing by increasing its share price above the minimum $1.00 requirement. InterCure Ltd. operates in the medical cannabis industry.
